StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
53
This month
2
This year
7
Publishing Date
2024 - 04 - 11
1
2024 - 04 - 09
1
2024 - 03 - 20
1
2024 - 03 - 05
1
2024 - 01 - 29
1
2024 - 01 - 03
1
2024 - 01 - 02
1
2023 - 11 - 29
1
2023 - 11 - 28
2
2023 - 11 - 21
1
2023 - 11 - 08
1
2023 - 08 - 30
1
2023 - 08 - 22
1
2023 - 08 - 02
1
2023 - 07 - 05
1
2023 - 05 - 19
1
2023 - 05 - 10
1
2023 - 05 - 03
1
2023 - 03 - 01
1
2023 - 02 - 28
1
2023 - 02 - 08
1
2023 - 01 - 12
1
2022 - 11 - 16
1
2022 - 11 - 03
1
2022 - 10 - 18
1
2022 - 09 - 30
1
2022 - 08 - 31
1
2022 - 08 - 15
1
2022 - 08 - 10
1
2022 - 08 - 03
1
2022 - 07 - 26
1
2022 - 07 - 14
3
2022 - 06 - 24
1
2022 - 05 - 24
1
2022 - 05 - 16
1
2022 - 05 - 04
1
2022 - 05 - 03
1
2022 - 04 - 04
1
2022 - 02 - 28
2
2022 - 02 - 11
1
2022 - 02 - 09
1
2022 - 02 - 04
1
2022 - 01 - 18
1
2021 - 12 - 08
1
2021 - 11 - 04
1
2021 - 10 - 27
1
2021 - 10 - 01
1
2021 - 09 - 30
1
2021 - 09 - 29
1
Sector
Communications
2
Health technology
53
N/a
16
Tags
Ajovy
2
Asia
3
Austedo
1
Avt03
1
Avt04
2
Avt05
1
Avt06
1
Biosimilar
5
Business
8
Candidate
1
Casirivimab
2
Children
4
China
1
Clinical-trials-phase-iii
2
Conference
11
Covid
2
Covid-19
1
Crispr
2
Diabetic
1
Disease
3
Dupixent
4
Earnings
14
Europe
3
Events
1
Eylea
1
Financial
21
Financial results
4
First
1
For
1
Genetown
2
Group
1
Huntington’s disease
1
Intel
2
Macular
2
Migraine
1
N/a
22
News
1
Ntla-2001
2
Pharm-country
1
Pharmaceutical
1
Phase 1
2
Phase 2
1
Phase 2 results
1
Phase 3
4
Positive
9
Prolia
1
Report
6
Research
3
Results
47
Revenue
1
Sanofi
1
Simponi
1
Six
2
Stelara
2
Study
4
Teva
11
Therapy
2
Trial
5
Update
11
Year
7
Entities
Abbvie inc.
92
Agnico eagle mines limited
51
Alnylam pharmaceuticals, inc.
81
Amgen inc.
55
Apollo global management, inc
41
Arrival
197
B2gold corp
44
Bank of montreal
41
Barrick gold corporation
50
Beigene, ltd.
52
Biontech se
54
Bnp paribas
82
Bristol-myers squibb company
73
Brookfield asset management inc
54
Coherus biosciences, inc.
48
Cvr partners, lp
52
Cytokinetics, incorporated
44
Eli lilly and company
219
Enbridge inc
42
First bank
95
Fortress biotech, inc.
61
Genmab a/s
48
Gilead sciences, inc.
55
Incyte corporation
77
Ionis pharmaceuticals, inc.
43
Jd.com, inc.
43
Jinkosolar holding company limited
42
Johnson & johnson
248
Kering
89
Lexicon pharmaceuticals, inc.
41
Ligand pharmaceuticals incorporated
46
Lithium corp
61
Marathon petroleum corporation
55
Medies
40
Mediwound ltd.
53
Medtronic plc
45
Morgan stanley
225
Mplx lp
53
Netease, inc.
59
Nextera energy partners, lp
48
Nextera energy, inc.
49
Novartis ag
59
Orange
374
Paid inc
198
Peabody energy corporation
40
Pfizer, inc.
64
Provention bio, inc.
46
Regeneron pharmaceuticals, inc.
88
Sanofi
393
Seagen inc.
40
Sempra energy
41
T2 biosystems, inc.
44
Takeda pharmaceutical company limited
71
Teekay corporation
49
Teekay tankers ltd.
48
Teva pharmaceutical industries ltd
53
X financial
104
Xencor, inc.
42
Yamana gold inc.
47
Youdao, inc.
46
Symbols
ABBV
5
ACET
1
ALVO
16
AMGN
4
CMPI
2
EGRX
2
ENDP
1
FNCTF
2
JNJ
5
KMDA
17
NTLA
3
NVS
2
NVSEF
2
RARE
1
REGN
15
SNY
15
SNYNF
15
TEVA
13
TEVJF
53
Exchanges
Nasdaq
53
Nyse
19
Crawled Date
2024 - 04 - 11
1
2024 - 04 - 09
1
2024 - 03 - 20
1
2024 - 03 - 05
1
2024 - 01 - 29
1
2024 - 01 - 03
2
2023 - 11 - 29
1
2023 - 11 - 28
2
2023 - 11 - 21
1
2023 - 11 - 08
1
2023 - 08 - 30
1
2023 - 08 - 22
1
2023 - 08 - 02
1
2023 - 07 - 05
1
2023 - 05 - 19
1
2023 - 05 - 10
1
2023 - 05 - 03
1
2023 - 03 - 01
1
2023 - 02 - 28
1
2023 - 02 - 08
1
2023 - 01 - 12
1
2022 - 11 - 16
1
2022 - 11 - 03
1
2022 - 10 - 18
1
2022 - 09 - 30
1
2022 - 08 - 31
1
2022 - 08 - 15
1
2022 - 08 - 10
1
2022 - 08 - 03
1
2022 - 07 - 26
1
2022 - 07 - 14
3
2022 - 06 - 24
1
2022 - 05 - 24
1
2022 - 05 - 16
1
2022 - 05 - 04
1
2022 - 05 - 03
1
2022 - 04 - 04
1
2022 - 02 - 28
2
2022 - 02 - 11
1
2022 - 02 - 09
1
2022 - 02 - 04
1
2022 - 01 - 18
1
2021 - 12 - 08
1
2021 - 11 - 04
1
2021 - 10 - 27
1
2021 - 10 - 01
1
2021 - 09 - 30
1
2021 - 09 - 29
1
Crawled Time
00:00
1
01:00
1
05:00
2
06:00
1
07:00
1
09:00
5
11:00
3
12:00
4
12:20
1
13:00
6
13:20
1
13:30
2
14:00
1
15:00
2
15:30
1
16:00
1
17:00
1
20:00
3
21:00
5
22:00
3
23:00
8
Source
www.biospace.com
31
www.globenewswire.com
16
www.prnewswire.com
6
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
results
entities :
Teva pharmaceutical industries ltd
save search
Teva Confirms Efficacy and Safety of AJOVY® (fremanezumab) for the Prevention of Migraine With Results from Phase 3 Trial in China
Published:
2024-04-11
(Crawled : 23:00)
- biospace.com/
TEVA
|
$12.86
0.63%
0.0%
10M
|
Health Technology
|
-7.15%
|
O:
-1.01%
H:
2.04%
C:
1.17%
ajovy
for
teva
trial
migraine
china
results
Teva to Host Conference Call to Discuss First Quarter 2024 Financial Results at 8 a.m. ET on May 8, 2024
Published:
2024-04-09
(Crawled : 23:00)
- biospace.com/
TEVA
|
$12.86
0.63%
0.0%
10M
|
Health Technology
|
-9.44%
|
O:
-0.7%
H:
0.07%
C:
-0.92%
first
conference
teva
financial
results
Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update
Published:
2024-03-20
(Crawled : 20:00)
- globenewswire.com
ALVO
|
News
|
$13.23
2.64%
2.57%
1.7M
|
n/a
|
-13.2%
|
O:
-1.58%
H:
1.87%
C:
0.53%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-4.93%
|
O:
-0.03%
H:
0.0%
C:
0.0%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-6.62%
|
O:
-0.89%
H:
0.0%
C:
0.0%
KMDA
|
News
|
$5.05
-0.98%
-0.99%
27K
|
Health Technology
|
-11.58%
|
O:
0.68%
H:
0.0%
C:
-1.86%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-1.51%
|
O:
0.58%
H:
1.2%
C:
0.84%
business
year
update
financial
results
Alvotech Announces Webcast of Full Year 2023 Financial Results on March 21, 2024, at 8:00 am ET
Published:
2024-03-05
(Crawled : 21:00)
- globenewswire.com
ALVO
|
News
|
$13.23
2.64%
2.57%
1.7M
|
n/a
|
-18.19%
|
O:
-0.99%
H:
0.75%
C:
-0.13%
KMDA
|
News
|
$5.05
-0.98%
-0.99%
27K
|
Health Technology
|
-18.52%
|
O:
-6.12%
H:
1.67%
C:
1.17%
year
financial
results
Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT03, a Proposed Biosimilar for Prolia® and Xgeva®
Published:
2024-01-29
(Crawled : 09:00)
- globenewswire.com
ALVO
|
News
|
$13.23
2.64%
2.57%
1.7M
|
n/a
|
-9.76%
|
O:
2.39%
H:
4.67%
C:
1.67%
KMDA
|
News
|
$5.05
-0.98%
-0.99%
27K
|
Health Technology
|
-9.58%
|
O:
-1.05%
H:
0.41%
C:
-0.35%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-13.74%
|
O:
-0.11%
H:
0.7%
C:
0.65%
avt03
prolia
biosimilar
positive
results
study
Alvotech Clinical Study Results Demonstrate Therapeutic Equivalence between Biosimilar Candidate AVT06 and Reference Product Eylea® (aflibercept)
Published:
2024-01-03
(Crawled : 09:00)
- globenewswire.com
ALVO
|
News
|
$13.23
2.64%
2.57%
1.7M
|
n/a
|
16.37%
|
O:
1.23%
H:
2.17%
C:
1.57%
KMDA
|
News
|
$5.05
-0.98%
-0.99%
27K
|
Health Technology
|
-15.75%
|
O:
-0.97%
H:
1.53%
C:
0.0%
avt06
eylea
candidate
biosimilar
results
study
Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and 2024 Financial Guidance at 8 a.m. ET on January 31, 2024
Published:
2024-01-02
(Crawled : 00:00)
- biospace.com/
TEVA
|
$12.86
0.63%
0.0%
10M
|
Health Technology
|
23.18%
|
O:
0.29%
H:
3.53%
C:
1.91%
conference
year
teva
financial
results
Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT05, a Proposed Biosimilar for Simponi® and Simponi Aria®
Published:
2023-11-29
(Crawled : 09:00)
- globenewswire.com
ALVO
|
News
|
$13.23
2.64%
2.57%
1.7M
|
n/a
|
34.9%
|
O:
1.02%
H:
0.0%
C:
-5.05%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-2.31%
|
O:
-0.04%
H:
0.0%
C:
0.0%
KMDA
|
News
|
$5.05
-0.98%
-0.99%
27K
|
Health Technology
|
8.46%
|
O:
0.73%
H:
0.0%
C:
-1.04%
avt05
simponi
biosimilar
positive
results
study
Alvotech Reports Financial Results for First Nine Months of 2023 and Provides Business Update
Published:
2023-11-28
(Crawled : 21:00)
- globenewswire.com
ALVO
|
News
|
$13.23
2.64%
2.57%
1.7M
|
n/a
|
34.9%
|
O:
1.02%
H:
0.0%
C:
-5.05%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-2.72%
|
O:
0.18%
H:
0.12%
C:
-0.16%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-2.31%
|
O:
-0.04%
H:
0.0%
C:
0.0%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
19.69%
|
O:
-0.73%
H:
0.78%
C:
0.35%
KMDA
|
News
|
$5.05
-0.98%
-0.99%
27K
|
Health Technology
|
8.46%
|
O:
0.73%
H:
0.0%
C:
-1.04%
business
update
financial
results
Alvotech Reports Financial Results for First Nine Months of 2023 and Provides a Business Update
Published:
2023-11-28
(Crawled : 21:00)
- globenewswire.com
ALVO
|
News
|
$13.23
2.64%
2.57%
1.7M
|
n/a
|
34.9%
|
O:
1.02%
H:
0.0%
C:
-5.05%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-2.31%
|
O:
-0.04%
H:
0.0%
C:
0.0%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
19.69%
|
O:
-0.73%
H:
0.78%
C:
0.35%
KMDA
|
News
|
$5.05
-0.98%
-0.99%
27K
|
Health Technology
|
8.46%
|
O:
0.73%
H:
0.0%
C:
-1.04%
business
update
financial
results
Alvotech to Report Financial Results for the First Nine Months of 2023 on November 28, 2023, and Host Business Update Conference Call on November 29, 2023, at 8:00 am ET
Published:
2023-11-21
(Crawled : 13:00)
- globenewswire.com
ALVO
|
News
|
$13.23
2.64%
2.57%
1.7M
|
n/a
|
44.64%
|
O:
-2.08%
H:
1.94%
C:
0.67%
KMDA
|
News
|
$5.05
-0.98%
-0.99%
27K
|
Health Technology
|
9.96%
|
O:
-0.21%
H:
1.06%
C:
0.85%
conference
report
business
update
financial
results
Teva Reports Third Quarter 2023 Financial Results and Increases Revenue Guidance
Published:
2023-11-08
(Crawled : 14:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
1.88%
|
O:
-0.33%
H:
0.0%
C:
0.0%
TEVA
|
$12.86
0.63%
0.0%
10M
|
Health Technology
|
42.26%
|
O:
2.54%
H:
3.23%
C:
-1.29%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
2.73%
|
O:
1.62%
H:
0.0%
C:
0.0%
revenue
teva
financial
results
Alvotech Reports Financial Results for First Six Months of 2023 and Provides Business Update
Published:
2023-08-30
(Crawled : 20:00)
- globenewswire.com
ALVO
|
News
|
$13.23
2.64%
2.57%
1.7M
|
n/a
|
35.87%
|
O:
0.21%
H:
3.28%
C:
1.54%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-10.68%
|
O:
-1.35%
H:
0.12%
C:
-1.03%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
12.29%
|
O:
0.16%
H:
0.0%
C:
0.0%
KMDA
|
News
|
$5.05
-0.98%
-0.99%
27K
|
Health Technology
|
-7.82%
|
O:
1.24%
H:
1.23%
C:
0.88%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
4.28%
|
O:
0.13%
H:
0.3%
C:
-0.73%
six
business
update
financial
results
Alvotech to Report Financial Results for the First Half of 2023 on August 30, 2023, and Host Business Update Conference Call on August 31, 2023, at 8:00 am ET
Published:
2023-08-22
(Crawled : 13:20)
- globenewswire.com
ALVO
|
News
|
$13.23
2.64%
2.57%
1.7M
|
n/a
|
35.87%
|
O:
-0.21%
H:
4.22%
C:
0.93%
KMDA
|
News
|
$5.05
-0.98%
-0.99%
27K
|
Health Technology
|
-6.99%
|
O:
-1.43%
H:
0.0%
C:
-0.73%
conference
report
business
update
financial
results
Teva Reports Second Quarter 2023 Financial Results
Published:
2023-08-02
(Crawled : 15:00)
- biospace.com/
TEVA
|
$12.86
0.63%
0.0%
10M
|
Health Technology
|
55.13%
|
O:
5.55%
H:
8.46%
C:
5.71%
teva
financial
results
Teva to Host Conference Call to Discuss Second Quarter 2023 Financial Results at 8 a.m. ET on August 2, 2023
Published:
2023-07-05
(Crawled : 23:00)
- biospace.com/
TEVA
|
$12.86
0.63%
0.0%
10M
|
Health Technology
|
71.93%
|
O:
0.4%
H:
2.93%
C:
-0.27%
conference
teva
financial
results
Alvotech Reports Financial Results for First three Months of 2023 and Provides Business Update
Published:
2023-05-19
(Crawled : 09:00)
- globenewswire.com
ALVO
|
News
|
$13.23
2.64%
2.57%
1.7M
|
n/a
|
59.66%
|
O:
8.94%
H:
0.0%
C:
-7.65%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-5.97%
|
O:
-0.36%
H:
1.01%
C:
0.82%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
16.01%
|
O:
0.29%
H:
1.35%
C:
0.87%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
19.98%
|
O:
0.64%
H:
1.56%
C:
0.9%
KMDA
|
News
|
$5.05
-0.98%
-0.99%
27K
|
Health Technology
|
9.26%
|
O:
2.31%
H:
1.86%
C:
-0.2%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
19.93%
|
O:
0.09%
H:
0.64%
C:
-0.45%
business
update
financial
results
Teva Reports First Quarter 2023 Financial Results and Reaffirms 2023 Non-GAAP Outlook
Published:
2023-05-10
(Crawled : 13:00)
- biospace.com/
TEVA
|
$12.86
0.63%
0.0%
10M
|
Health Technology
|
41.32%
|
O:
-8.46%
H:
2.1%
C:
0.24%
teva
financial
results
Alvotech to Report First Quarter 2023 Financial Results and Recent Business Highlights on May 18, 2023 and Host Conference Call on May 19, 2023 at 8:00 am ET
Published:
2023-05-03
(Crawled : 13:00)
- globenewswire.com
ALVO
|
News
|
$13.23
2.64%
2.57%
1.7M
|
n/a
|
34.21%
|
O:
2.54%
H:
0.45%
C:
-2.97%
KMDA
|
News
|
$5.05
-0.98%
-0.99%
27K
|
Health Technology
|
13.57%
|
O:
3.94%
H:
1.89%
C:
-0.63%
conference
report
business
financial
results
Alvotech Reports Financial Results for Full Year 2022 and Provides Business Update
Published:
2023-03-01
(Crawled : 22:00)
- globenewswire.com
ALVO
|
News
|
$13.23
2.64%
2.57%
1.7M
|
n/a
|
-5.03%
|
O:
-1.29%
H:
2.62%
C:
2.11%
KMDA
|
News
|
$5.05
-0.98%
-0.99%
27K
|
Health Technology
|
17.95%
|
O:
-1.14%
H:
1.15%
C:
-0.92%
year
financial
update
← Previous
1
2
3
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.